📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Kineta

1.1 - Company Overview

Kineta Logo

Kineta

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotechnology discovery and development focused on antiviral therapies and immune-modulating drugs for RNA viruses—including hepatitis C, influenza, West Nile virus, and the common cold—and aiming to develop therapeutics for autoimmune disease, viral disease, and chronic pain.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Kineta

Replimune Logo

Replimune

HQ: United States Website
  • Description: Provider of next-generation oncolytic immunotherapies for cancer, developing proprietary products that enhance direct anti-tumor effects of selective virus replication and boost immune responses to tumor antigens. Products include RP1 (HSV-1 strain with immune-activating transgenes), RP2 (anti-CTLA-4 antibody targeting immunologically silent tumors to enhance tumor killing and immune response), and RP3 (CD40L and 4-1BBL ligands).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Replimune company profile →
Ab Initio Biotherapeutics Logo

Ab Initio Biotherapeutics

HQ: United States Website
  • Description: Provider of antigen discovery and antibody generation solutions using a proprietary platform targeting multi-transmembrane proteins such as GPCRs, supporting therapeutics for neurological, cardiovascular, endocrine and gastrointestinal disorders; offerings include antibody optimization, single B-cell screening of immune repertoires, the OmniAb Discovery Platform, OmniRat and OmniMouse with high-throughput screening.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ab Initio Biotherapeutics company profile →
XBiotech Logo

XBiotech

HQ: United States Website
  • Description: Provider of antibody therapy development as a biopharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full XBiotech company profile →
Adicet Bio Logo

Adicet Bio

HQ: United States Website
  • Description: Provider of first-in-class allogeneic gamma delta CAR T cell therapies for cancer, including ADI-001 targeting B-cells for B cell-mediated autoimmune diseases and B-cell non-Hodgkin’s lymphoma; ADI-270 targeting CD70 for solid tumors such as renal cell carcinoma; and an armored PSMA CAR program for metastatic castration-resistant prostate cancer. Expanded access is currently not provided.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adicet Bio company profile →
MedImmune Logo

MedImmune

HQ: United States Website
  • Description: Provider of biologics research and development as the global biologics research and development arm of AstraZeneca, developing medicines for unmet medical needs worldwide and pioneering innovative research and exploring novel pathways across key therapeutic areas including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; and neuroscience.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MedImmune company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Kineta

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Kineta

2.2 - Growth funds investing in similar companies to Kineta

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Kineta

4.2 - Public trading comparable groups for Kineta

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Kineta

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Kineta

What does Kineta do?

Kineta is a provider of biotechnology discovery and development focused on antiviral therapies and immune-modulating drugs for RNA viruses—including hepatitis C, influenza, West Nile virus, and the common cold—and aiming to develop therapeutics for autoimmune disease, viral disease, and chronic pain.

Who are Kineta's competitors?

Kineta's competitors and similar companies include Replimune, Ab Initio Biotherapeutics, XBiotech, Adicet Bio, and MedImmune.

Where is Kineta headquartered?

Kineta is headquartered in United States.

How many employees does Kineta have?

Kineta has 1,000 employees 🔒.

When was Kineta founded?

Kineta was founded in 2010 🔒.

What sector and industry vertical is Kineta in?

Kineta is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Kineta

Who are the top strategic acquirers in Kineta's sector and industry

Top strategic M&A buyers and acquirers in Kineta's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Kineta?

Top strategic M&A buyers groups and sectors for Kineta include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Kineta's sector and industry vertical

Which are the top PE firms investing in Kineta's sector and industry vertical?

Top PE firms investing in Kineta's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Kineta's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Kineta's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Kineta's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Kineta include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Kineta's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Kineta?

The key public trading comparables and valuation benchmarks for Kineta include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Kineta for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Kineta with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Kineta's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Kineta with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Kineta's' sector and industry vertical?

Access recent funding rounds and capital raises in Kineta's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Kineta